1. Home
  2. SILO vs ICU Comparison

SILO vs ICU Comparison

Compare SILO & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • ICU
  • Stock Information
  • Founded
  • SILO 2010
  • ICU 2018
  • Country
  • SILO United States
  • ICU United States
  • Employees
  • SILO N/A
  • ICU N/A
  • Industry
  • SILO Apparel
  • ICU Biotechnology: Pharmaceutical Preparations
  • Sector
  • SILO Consumer Discretionary
  • ICU Health Care
  • Exchange
  • SILO Nasdaq
  • ICU Nasdaq
  • Market Cap
  • SILO 8.8M
  • ICU 10.4M
  • IPO Year
  • SILO N/A
  • ICU N/A
  • Fundamental
  • Price
  • SILO $0.84
  • ICU $1.26
  • Analyst Decision
  • SILO
  • ICU
  • Analyst Count
  • SILO 0
  • ICU 0
  • Target Price
  • SILO N/A
  • ICU N/A
  • AVG Volume (30 Days)
  • SILO 175.9K
  • ICU 102.7K
  • Earning Date
  • SILO 05-16-2025
  • ICU 05-13-2025
  • Dividend Yield
  • SILO N/A
  • ICU N/A
  • EPS Growth
  • SILO N/A
  • ICU N/A
  • EPS
  • SILO N/A
  • ICU N/A
  • Revenue
  • SILO $72,102.00
  • ICU $135,000.00
  • Revenue This Year
  • SILO $1.86
  • ICU $648.15
  • Revenue Next Year
  • SILO N/A
  • ICU $100.00
  • P/E Ratio
  • SILO N/A
  • ICU N/A
  • Revenue Growth
  • SILO N/A
  • ICU N/A
  • 52 Week Low
  • SILO $0.72
  • ICU $1.11
  • 52 Week High
  • SILO $4.50
  • ICU $13.85
  • Technical
  • Relative Strength Index (RSI)
  • SILO 35.28
  • ICU 35.11
  • Support Level
  • SILO $0.71
  • ICU $1.24
  • Resistance Level
  • SILO $0.85
  • ICU $1.32
  • Average True Range (ATR)
  • SILO 0.09
  • ICU 0.06
  • MACD
  • SILO -0.01
  • ICU 0.02
  • Stochastic Oscillator
  • SILO 21.85
  • ICU 49.71

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

Share on Social Networks: